101 related articles for article (PubMed ID: 21315506)
1. Inhibition of topoisomerase IIα: novel function of wedelolactone.
Benes P; Knopfova L; Trcka F; Nemajerova A; Pinheiro D; Soucek K; Fojta M; Smarda J
Cancer Lett; 2011 Apr; 303(1):29-38. PubMed ID: 21315506
[TBL] [Abstract][Full Text] [Related]
2. Redox state alters anti-cancer effects of wedelolactone.
Benes P; Alexova P; Knopfova L; Spanova A; Smarda J
Environ Mol Mutagen; 2012 Aug; 53(7):515-24. PubMed ID: 22733624
[TBL] [Abstract][Full Text] [Related]
3. Quinacrine has anticancer activity in breast cancer cells through inhibition of topoisomerase activity.
Preet R; Mohapatra P; Mohanty S; Sahu SK; Choudhuri T; Wyatt MD; Kundu CN
Int J Cancer; 2012 Apr; 130(7):1660-70. PubMed ID: 21544805
[TBL] [Abstract][Full Text] [Related]
4. Wedelolactone induces growth of breast cancer cells by stimulation of estrogen receptor signalling.
Nehybova T; Smarda J; Daniel L; Brezovsky J; Benes P
J Steroid Biochem Mol Biol; 2015 Aug; 152():76-83. PubMed ID: 25934092
[TBL] [Abstract][Full Text] [Related]
5. Phenolic-containing organic extracts of mulberry (Morus alba L.) leaves inhibit HepG2 hepatoma cells through G2/M phase arrest, induction of apoptosis, and inhibition of topoisomerase IIα activity.
Naowaratwattana W; De-Eknamkul W; De Mejia EG
J Med Food; 2010 Oct; 13(5):1045-56. PubMed ID: 20828312
[TBL] [Abstract][Full Text] [Related]
6. A-62176, a potent topoisomerase inhibitor, inhibits the expression of human epidermal growth factor receptor 2.
Kim HL; Jeon KH; Jun KY; Choi Y; Kim DK; Na Y; Kwon Y
Cancer Lett; 2012 Dec; 325(1):72-9. PubMed ID: 22732416
[TBL] [Abstract][Full Text] [Related]
7. The iron chelator Dp44mT causes DNA damage and selective inhibition of topoisomerase IIalpha in breast cancer cells.
Rao VA; Klein SR; Agama KK; Toyoda E; Adachi N; Pommier Y; Shacter EB
Cancer Res; 2009 Feb; 69(3):948-57. PubMed ID: 19176392
[TBL] [Abstract][Full Text] [Related]
8. A cysteine-reactive alkyl hydroquinone modifies topoisomerase IIα, enhances DNA breakage, and induces apoptosis in cancer cells.
Lin TY; Huang CP; Au LC; Chang YW; Hu CY; Lin SB
Chem Res Toxicol; 2012 Nov; 25(11):2340-51. PubMed ID: 23088786
[TBL] [Abstract][Full Text] [Related]
9. Ethonafide-induced cytotoxicity is mediated by topoisomerase II inhibition in prostate cancer cells.
Pourpak A; Landowski TH; Dorr RT
J Pharmacol Exp Ther; 2007 Jun; 321(3):1109-17. PubMed ID: 17351106
[TBL] [Abstract][Full Text] [Related]
10. Oxocrebanine: A Novel Dual Topoisomerase inhibitor, Suppressed the Proliferation of Breast Cancer Cells MCF-7 by Inducing DNA Damage and Mitotic Arrest.
Yu L; Han S; Lang L; Song H; Zhang C; Dong L; Jia S; Zhang Y; Xiao D; Liu J; Xu Y; Zhang X
Phytomedicine; 2021 Apr; 84():153504. PubMed ID: 33611211
[TBL] [Abstract][Full Text] [Related]
11. Thiosemicarbazones and 4-thiazolidinones indole-based derivatives: Synthesis, evaluation of antiproliferative activity, cell death mechanisms and topoisomerase inhibition assay.
de Oliveira JF; Lima TS; Vendramini-Costa DB; de Lacerda Pedrosa SCB; Lafayette EA; da Silva RMF; de Almeida SMV; de Moura RO; Ruiz ALTG; de Carvalho JE; de Lima MDCA
Eur J Med Chem; 2017 Aug; 136():305-314. PubMed ID: 28505535
[TBL] [Abstract][Full Text] [Related]
12. Sodium salicylate is a novel catalytic inhibitor of human DNA topoisomerase II alpha.
Bau JT; Kurz EU
Biochem Pharmacol; 2011 Feb; 81(3):345-54. PubMed ID: 20959117
[TBL] [Abstract][Full Text] [Related]
13. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
[TBL] [Abstract][Full Text] [Related]
14. Targeting the DNA-topoisomerase complex in a double-strike approach with a topoisomerase inhibiting moiety and covalent DNA binder.
Kurzwernhart A; Kandioller W; Bartel C; Bächler S; Trondl R; Mühlgassner G; Jakupec MA; Arion VB; Marko D; Keppler BK; Hartinger CG
Chem Commun (Camb); 2012 May; 48(40):4839-41. PubMed ID: 22498692
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of 4β-sulphonamido and 4β-[(4'-sulphonamido)benzamide]podophyllotoxins as DNA topoisomerase-IIα and apoptosis inducing agents.
Kamal A; Suresh P; Ramaiah MJ; Mallareddy A; Imthiajali S; Pushpavalli SN; Lavanya A; Pal-Bhadra M
Bioorg Med Chem; 2012 Mar; 20(6):2054-66. PubMed ID: 22364746
[TBL] [Abstract][Full Text] [Related]
16. Topoisomerase IIalpha mediates E2F-1-induced chemosensitivity and is a target for p53-mediated transcriptional repression.
Nip J; Hiebert SW
Cell Biochem Biophys; 2000; 33(2):199-207. PubMed ID: 11325040
[TBL] [Abstract][Full Text] [Related]
17. A novel p-terphenyl derivative inducing cell-cycle arrest and apoptosis in MDA-MB-435 cells through topoisomerase inhibition.
Qiu J; Zhao B; Shen Y; Chen W; Ma Y; Shen Y
Eur J Med Chem; 2013 Oct; 68():192-202. PubMed ID: 23974019
[TBL] [Abstract][Full Text] [Related]
18. N-fused imidazoles as novel anticancer agents that inhibit catalytic activity of topoisomerase IIα and induce apoptosis in G1/S phase.
Baviskar AT; Madaan C; Preet R; Mohapatra P; Jain V; Agarwal A; Guchhait SK; Kundu CN; Banerjee UC; Bharatam PV
J Med Chem; 2011 Jul; 54(14):5013-30. PubMed ID: 21644529
[TBL] [Abstract][Full Text] [Related]
19. DNA topoisomerase IIalpha (TOP2A) inhibitors up-regulate fatty acid synthase gene expression in SK-Br3 breast cancer cells: in vitro evidence for a 'functional amplicon' involving FAS, Her-2/neu and TOP2A genes.
Menendez JA; Vellon L; Lupu R
Int J Mol Med; 2006 Dec; 18(6):1081-7. PubMed ID: 17089011
[TBL] [Abstract][Full Text] [Related]
20. Daurinol, a catalytic inhibitor of topoisomerase IIα, suppresses SNU-840 ovarian cancer cell proliferation through cell cycle arrest in S phase.
Kang K; Nho CW; Kim ND; Song DG; Park YG; Kim M; Pan CH; Shin D; Oh SH; Oh HS
Int J Oncol; 2014 Aug; 45(2):558-66. PubMed ID: 24841075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
